Usana Health Sciences INC Form 4 insider transactions

Director Ding Xia reports acquisition of 2,697 restricted stock units in USANA Health Sciences, vesting in installments through May 2025.

Daniel A. Macuga, Chief Communications Officer of USANA Health Sciences, sold 3,791 shares of common stock on May 2, 2024.

Director Timothy Wood reported the vesting of restricted stock units and subsequent acquisition of common stock in USANA Health Sciences.

Frederic J. Winssinger, a director at USANA Health Sciences, exercised stock options and acquired 490 shares of common stock on April 24, 2024.

J Scott Nixon, a director at USANA Health Sciences, reported the vesting and subsequent acquisition of 490 shares of common stock on April 24, 2024, related to restricted stock units.

Peggie Pelosi, a director at USANA Health Sciences, reported the vesting and subsequent disposal of restricted stock units on April 24, 2024.

Director Gilbert A. Fuller reported the vesting of 490 restricted stock units into common stock of USANA Health Sciences on April 24, 2024.

Director John Turman Fleming exercised restricted stock units for USANA Health Sciences common stock on April 24, 2024.

Director Ding Xia of USANA Health Sciences reported the vesting of restricted stock units and subsequent stock sales to cover tax obligations.

Kevin Guest, Executive Chairman of USANA Health Sciences, sold 11,011 shares of common stock at $49 per share on March 11, 2024.

Walter Noot, Chief Operating Officer of USANA Health Sciences Inc., disposed of 5,240 shares of common stock at an average price of $49.05 on March 8, 2024.

Brent Neidig, a USANA Health Sciences Inc. officer, sold 3,810 shares of common stock on March 6, 2024.

Robert A. Sinnott, Chief Scientific Officer of USANA Health Sciences Inc, reported the sale of 3,945 shares of common stock on March 5, 2024.

Director John Turman Fleming of USANA Health Sciences Inc. sold 300 shares of common stock on March 4, 2024, at a price of $48.9882 per share.

Director Gilbert A Fuller of USANA Health Sciences Inc. sold 491 shares of common stock on March 4, 2024, at a price of $49.0748 per share.

Director Peggie Pelosi sold 485 shares of USANA Health Sciences Inc. on February 29, 2024, at a price of $48.146 per share.

Daniel A. Macuga, Chief Communications Officer of USANA Health Sciences, reported the sale of 1,500 shares of common stock on March 1, 2024.

David Mulham, Chief Sales Officer of USANA Health Sciences, sold 4,311 shares of common stock on February 29, 2024.

Joshua Foukas, Chief Legal Officer of USANA Health Sciences Inc., reported the sale of 4,847 shares of common stock on February 29, 2024.